We are proud to be part of the C19 Coalition to increase the supply of PPE, enable more accessible PPE procurement for frontline healthcare organizations with non-profit bridge financing capital, and to share data to allow PPE supply chains to respond to demand https://t.co/fgiOoLTSGf
GreenLight Biosciences raises $17m to ramp mRNA production for COVID-19 vaccine candidate trials
The Search for a Universal Flu Vaccine Heats Up
Experts debate urgency of better flu shot, drug prices, nonprofit R&D models
University of Cambridge’s Prof Jonathan Heeney answers call to transform flu vaccine
Oregon Health & Science University doc dreams of lifetime immunity with one flu shot
UChicago-Led Effort Receives Grant For Research Developing Universal Influenza Vaccine
With new grants, Flu Lab and Gates Foundation take an early step toward a universal flu vaccine
Flu Lab Announcements
Flu Lab announced a new partnership with the Center for Open Science and the Public Library of Science to expand the publication of null and negative influenza research findings and support influenza replication studies. Researchers are invited to submit proposals to the Call for Negative Results, Null results, and Replication of Important Findings.
In 2018 the Gates Foundation and Flu Lab issued a "Grand Challenge" for novel and transformative approaches to developing a universal influenza vaccine. We recently announced seven grantees who represent a diverse set of backgrounds, areas of expertise, and geographies and who are approaching the search for a universal influenza vaccine in new and exciting ways.
A new report, “Accelerating the Development of a Universal Influenza Vaccine,” has been released by the Sabin-Aspen Vaccine Science & Policy Group, a joint initiative of the Sabin Vaccine Institute and the Aspen Institute. It calls for an urgent, coordinated effort to amplify and focus resources on the long-sought, but overdue achievement of a universal influenza vaccine.